FDA Announces Update on Tandem Diabetes Care’s Recall of t:connect Mobile App
WASHINGTON, D.C. — The Food and Drug Administration (FDA) has provided an important update regarding the ongoing recall of the Apple iOS t:connect mobile app by Tandem Diabetes Care, Inc. (Nasdaq: …
FDA Announces Update on Tandem Diabetes Care’s Recall of t:connect Mobile App Read More